locus H19
Showing 1 - 25 of >10,000
Non-hodgkin Lymphoma,B Cell Trial in Beijing (Autologous CD19-STAR-T cell, Fludarabine, Cyclophosphamide)
Recruiting
- Non-hodgkin Lymphoma,B Cell
- Autologous CD19-STAR-T cell
- +2 more
-
Beijing, Beijing, China
- +1 more
Nov 21, 2022
H19 in Acute Lymphoblastic Leukemia.
Not yet recruiting
- Acute Lymphoid Leukemia
- (no location specified)
Jul 11, 2023
B-Cell Lymphoma, Large B-cell Lymphoma, DLBCL, Nos Genetic Subtypes Trial in New York (19(T2)28z1xx TRAC T cell)
Recruiting
- B-Cell Lymphoma
- +4 more
- 19(T2)28z1xx TRAC T cell
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Feb 24, 2023
Solid Tumor, Hematological Malignancy Trial in Fairfax (Locus Health iPhone App)
Not yet recruiting
- Solid Tumor
- Hematological Malignancy
- Locus Health iPhone App
-
Fairfax, VirginiaInova Schar Cancer Institute
Oct 24, 2023
Role of LncRNA H19 in The Regulation of IGF-1R Expression
Completed
- Hepatocellular Carcinoma
- +2 more
- Blood sample collection
-
Mansoura, Dakahliya, Egypt
- +1 more
Apr 5, 2022
Covid19, Hydrogen-oxygen Gas, AMS-H-03 Trial in Guangzhou (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, OLO-1 Medical
Not yet recruiting
- Covid19
- +2 more
- Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
- OLO-1 Medical Molecular Sieve Oxygen Generator
-
Guangzhou, Guangdong, ChinaFirst Affiliated Hospital of Guangzhou Medical University
Mar 12, 2023
Covid19 Trial in Graz (Omni-Biotic Pro Vi 5, Placebo)
Active, not recruiting
- Covid19
- Omni-Biotic Pro Vi 5
- Placebo
-
Graz, AustriaMedical University Graz
Sep 26, 2022
Covid19 Trial in Montréal (Dalcetrapib, Placebo)
Completed
- Covid19
- Dalcetrapib
- Placebo
-
Montréal, Quebec, CanadaInstitut de Cardiologie de Montréal
Nov 10, 2022
COVID-19, Virus Diseases, Corona Virus Infection Trial in Athens (Sodium Thiosulfate 25% Solution for Injection)
Recruiting
- COVID-19
- +2 more
- Sodium Thiosulfate 25% Solution for Injection
-
Athens, Kifisia, GreeceGeneral Hospitan of Athens KAT 2nd Department of ICU
Jan 11, 2023
Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Spain (ARI0003)
Not yet recruiting
- Refractory Non-Hodgkin Lymphoma
- Relapsed Non-Hodgkin Lymphoma
- ARI0003
-
Santiago De Compostela, A Coruña, Spain
- +6 more
Oct 24, 2023
Covid19, Hydrogen-oxygen Gas, AMS-H-03 Trial in Shanghai (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, the hospital
Active, not recruiting
- Covid19
- +2 more
- Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
- the hospital routine oxygen supply equipment (wall oxygen or cylinder oxygen)
-
Shanghai, Shanghai, ChinaRuijin Hospital, Medical School of Shanghai Jiaotong University
Sep 13, 2022
Long COVID, Chronic Fatigue Syndrome Trial in Sherbrooke (Telerehabilitation program based on cardiorespiratory principles)
Completed
- Long COVID
- Chronic Fatigue Syndrome
- Telerehabilitation program based on cardiorespiratory principles
-
Sherbrooke, Quebec, CanadaUniversité de Sherbrooke
Jul 28, 2023
COVID-19, AMS-H-03, Hydrogen-oxygen Gas Trial in Shanghai (Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03, basic treatment)
Recruiting
- COVID-19
- +2 more
- Hydrogen-Oxygen Generator with Nebulizer, AMS-H-03
- basic treatment
-
Shanghai, Shanghai, ChinaZhongshan Hospital affiliated to Fudan University
Aug 16, 2022
How do Perceptions of Coronavirus Disease Risk Influence Health
Recruiting
- Pregnancy Related
-
Vancouver, British Columbia, Canada
- +1 more
Jan 9, 2023
COVID-19 Trial in Napoli, Roma (Hydrogen peroxide, Placebo)
Withdrawn
- COVID-19
- Hydrogen peroxide
- Placebo
-
Roma, ItalyClinica Nuova ITOR
Nov 20, 2022
Glaucoma, Depression, Anxiety Trial in London (Art of Meditation)
Not yet recruiting
- Glaucoma
- +4 more
- Art of Meditation
-
London, Ontario, CanadaSt. Joseph's Hospital, Ivey Eye Institute
Jan 20, 2023
COVID-19 Trial in Sherbrooke (Probiotics, Placebo)
Active, not recruiting
- COVID-19
- Probiotics
- Placebo
-
Sherbrooke, Quebec, CanadaCIUSSS de L'Estrie-CHUS Hospital
Sep 27, 2022
Covid19 Trial in Niagara, Toronto, Montreal (Omalizumab, Placebo)
Active, not recruiting
- Covid19
- Omalizumab
- Placebo
-
Niagara, Ontario, Canada
- +2 more
Nov 14, 2022
COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)
Recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901a
-
Halifax, Nova Scotia, Canada
- +6 more
Nov 16, 2022
COVID-19 Pandemic, Health Knowledge, Attitudes, Practice, Perinatal Depression Trial in Chicago, Providence (Baby2Home Mobile
Recruiting
- COVID-19 Pandemic
- +4 more
- Baby2Home Mobile Application
-
Chicago, Illinois
- +1 more
Nov 10, 2022
Scleroderma, Scleroderma, Systemic, Systemic Sclerosis Trial in Montreal (SPIN-CHAT Program)
Completed
- Scleroderma
- +2 more
- SPIN-CHAT Program
-
Montreal, Quebec, CanadaSir Mortimer B. Davis Jewish General Hospital
May 2, 2022
COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)
Not yet recruiting
- COVID-19
- Coronavirus Infections
- VBI-2901e
-
Halifax, Nova Scotia, Canada
- +3 more
Dec 10, 2022
Parkinson Disease, Covid19, Satisfaction, Patient Trial in Towson (No Intervention)
Recruiting
- Parkinson Disease
- +3 more
- No Intervention
-
Towson, MarylandTowson University
Mar 30, 2021
Covid-19 Trial in Grenoble (Mixture 3,6% H2 in N2 (96.4%))
Recruiting
- Covid-19
- Mixture 3,6% H2 in N2 (96.4%)
-
Grenoble, FranceCHU de Grenoble Alpes
May 24, 2022
SARS-CoV-2, Covid-19, Coronavirus Trial in Miami (Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test)
Withdrawn
- SARS-CoV-2
- +2 more
- Xiamen Wiz Biotech Co., Ltd. SARS-CoV-2 Antigen Rapid Test
-
Miami, FloridaD&H National Research Centers INC
Aug 3, 2022